The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Preventive Vaccines Market Research Report 2025
Synopsis
Preventive vaccines are targeted at healthy populations and are available to susceptible populations.It refers to the preventive vaccination of the patient before the infection of the pathogen or in the body without the disease.
The global Preventive Vaccines market was valued at US$ 54560 million in 2023 and is anticipated to reach US$ 98050 million by 2030, witnessing a CAGR of 8.6% during the forecast period 2024-2030.
North American market for Preventive Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Preventive Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Preventive Vaccines include Sanofi, AstraZeneca, CSL Ltd, Abbott, GlaxoSmithKline and Serum Institute of India, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Preventive Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preventive Vaccines.
Report Scope
The Preventive Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Preventive Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preventive Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
AstraZeneca
CSL Ltd
Abbott
GlaxoSmithKline
Serum Institute of India
Segment by Type
Intramuscular Injection
Nasal Spray
Intradermal Shot
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Preventive Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Preventive Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Preventive vaccines are targeted at healthy populations and are available to susceptible populations.It refers to the preventive vaccination of the patient before the infection of the pathogen or in the body without the disease.
The global Preventive Vaccines market was valued at US$ 54560 million in 2023 and is anticipated to reach US$ 98050 million by 2030, witnessing a CAGR of 8.6% during the forecast period 2024-2030.
North American market for Preventive Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Preventive Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Preventive Vaccines include Sanofi, AstraZeneca, CSL Ltd, Abbott, GlaxoSmithKline and Serum Institute of India, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Preventive Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preventive Vaccines.
Report Scope
The Preventive Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Preventive Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preventive Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
AstraZeneca
CSL Ltd
Abbott
GlaxoSmithKline
Serum Institute of India
Segment by Type
Intramuscular Injection
Nasal Spray
Intradermal Shot
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Preventive Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Preventive Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Preventive Vaccines Market Overview
1.1 Product Overview and Scope of Preventive Vaccines
1.2 Preventive Vaccines Segment by Type
1.2.1 Global Preventive Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Intramuscular Injection
1.2.3 Nasal Spray
1.2.4 Intradermal Shot
1.3 Preventive Vaccines Segment by Application
1.3.1 Global Preventive Vaccines Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Preventive Vaccines Market Size Estimates and Forecasts
1.4.1 Global Preventive Vaccines Revenue 2019-2030
1.4.2 Global Preventive Vaccines Sales 2019-2030
1.4.3 Global Preventive Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Preventive Vaccines Market Competition by Manufacturers
2.1 Global Preventive Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Preventive Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Preventive Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Preventive Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Preventive Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Preventive Vaccines, Product Type & Application
2.7 Preventive Vaccines Market Competitive Situation and Trends
2.7.1 Preventive Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Preventive Vaccines Players Market Share by Revenue
2.7.3 Global Preventive Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Preventive Vaccines Retrospective Market Scenario by Region
3.1 Global Preventive Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Preventive Vaccines Global Preventive Vaccines Sales by Region: 2019-2030
3.2.1 Global Preventive Vaccines Sales by Region: 2019-2024
3.2.2 Global Preventive Vaccines Sales by Region: 2025-2030
3.3 Global Preventive Vaccines Global Preventive Vaccines Revenue by Region: 2019-2030
3.3.1 Global Preventive Vaccines Revenue by Region: 2019-2024
3.3.2 Global Preventive Vaccines Revenue by Region: 2025-2030
3.4 North America Preventive Vaccines Market Facts & Figures by Country
3.4.1 North America Preventive Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Preventive Vaccines Sales by Country (2019-2030)
3.4.3 North America Preventive Vaccines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Preventive Vaccines Market Facts & Figures by Country
3.5.1 Europe Preventive Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Preventive Vaccines Sales by Country (2019-2030)
3.5.3 Europe Preventive Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Preventive Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Preventive Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Preventive Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Preventive Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Preventive Vaccines Market Facts & Figures by Country
3.7.1 Latin America Preventive Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Preventive Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Preventive Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Preventive Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Preventive Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Preventive Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Preventive Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Preventive Vaccines Sales by Type (2019-2030)
4.1.1 Global Preventive Vaccines Sales by Type (2019-2024)
4.1.2 Global Preventive Vaccines Sales by Type (2025-2030)
4.1.3 Global Preventive Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Preventive Vaccines Revenue by Type (2019-2030)
4.2.1 Global Preventive Vaccines Revenue by Type (2019-2024)
4.2.2 Global Preventive Vaccines Revenue by Type (2025-2030)
4.2.3 Global Preventive Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Preventive Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Preventive Vaccines Sales by Application (2019-2030)
5.1.1 Global Preventive Vaccines Sales by Application (2019-2024)
5.1.2 Global Preventive Vaccines Sales by Application (2025-2030)
5.1.3 Global Preventive Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Preventive Vaccines Revenue by Application (2019-2030)
5.2.1 Global Preventive Vaccines Revenue by Application (2019-2024)
5.2.2 Global Preventive Vaccines Revenue by Application (2025-2030)
5.2.3 Global Preventive Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Preventive Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Preventive Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Preventive Vaccines Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Preventive Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AstraZeneca Preventive Vaccines Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 CSL Ltd
6.3.1 CSL Ltd Corporation Information
6.3.2 CSL Ltd Description and Business Overview
6.3.3 CSL Ltd Preventive Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CSL Ltd Preventive Vaccines Product Portfolio
6.3.5 CSL Ltd Recent Developments/Updates
6.4 Abbott
6.4.1 Abbott Corporation Information
6.4.2 Abbott Description and Business Overview
6.4.3 Abbott Preventive Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Abbott Preventive Vaccines Product Portfolio
6.4.5 Abbott Recent Developments/Updates
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Corporation Information
6.5.2 GlaxoSmithKline Description and Business Overview
6.5.3 GlaxoSmithKline Preventive Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 GlaxoSmithKline Preventive Vaccines Product Portfolio
6.5.5 GlaxoSmithKline Recent Developments/Updates
6.6 Serum Institute of India
6.6.1 Serum Institute of India Corporation Information
6.6.2 Serum Institute of India Description and Business Overview
6.6.3 Serum Institute of India Preventive Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Serum Institute of India Preventive Vaccines Product Portfolio
6.6.5 Serum Institute of India Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Preventive Vaccines Industry Chain Analysis
7.2 Preventive Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Preventive Vaccines Production Mode & Process
7.4 Preventive Vaccines Sales and Marketing
7.4.1 Preventive Vaccines Sales Channels
7.4.2 Preventive Vaccines Distributors
7.5 Preventive Vaccines Customers
8 Preventive Vaccines Market Dynamics
8.1 Preventive Vaccines Industry Trends
8.2 Preventive Vaccines Market Drivers
8.3 Preventive Vaccines Market Challenges
8.4 Preventive Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
